Creative Financial Designs Inc. ADV Sells 317 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)

Creative Financial Designs Inc. ADV lessened its position in shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) by 5.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 5,313 shares of the company’s stock after selling 317 shares during the period. Creative Financial Designs Inc. ADV’s holdings in Invesco Biotechnology & Genome ETF were worth $353,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of PBE. Raymond James Financial Inc. bought a new stake in Invesco Biotechnology & Genome ETF during the 4th quarter worth approximately $1,256,000. Jane Street Group LLC bought a new stake in Invesco Biotechnology & Genome ETF during the 3rd quarter worth approximately $295,000. Commonwealth Equity Services LLC increased its holdings in Invesco Biotechnology & Genome ETF by 16.9% during the 4th quarter. Commonwealth Equity Services LLC now owns 26,002 shares of the company’s stock worth $1,730,000 after acquiring an additional 3,764 shares during the period. HighTower Advisors LLC increased its holdings in Invesco Biotechnology & Genome ETF by 64.1% during the 3rd quarter. HighTower Advisors LLC now owns 7,101 shares of the company’s stock worth $494,000 after acquiring an additional 2,774 shares during the period. Finally, Farther Finance Advisors LLC purchased a new position in Invesco Biotechnology & Genome ETF in the 4th quarter worth approximately $161,000.

Invesco Biotechnology & Genome ETF Price Performance

PBE stock opened at $65.56 on Wednesday. Invesco Biotechnology & Genome ETF has a one year low of $59.32 and a one year high of $72.84. The stock has a market cap of $239.95 million, a PE ratio of 22.64 and a beta of 0.80. The firm has a 50 day simple moving average of $67.65 and a two-hundred day simple moving average of $68.61.

Invesco Biotechnology & Genome ETF Profile

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.